---
phase: GB-22-composition-and-microtest-evidence
plan: "02"
subsystem: testing
tags: [diagnostic-evidence, metadata, admission, no-go]
requires:
  - phase: GB-22-composition-and-microtest-evidence
    provides: Synthetic composition tracing and immutable diagnostic identity controls
provides:
  - Source-bound acid2 and gbmicrotest metadata assessment retained as blocked
  - Public no-go disposition that preserves all seven real-fixture gates
affects: [diagnostic-admission, phase-20-fixtures, phase-22]
actuals:
  tokens: 2100
  tasks: 2
  commits: 1
tech-stack:
  added: []
  patterns: [Metadata-only assessment with explicit real-fixture refusal]
key-files:
  created: [.planning/phases/GB-22-composition-and-microtest-evidence/22-02-SUMMARY.md]
  modified: [docs/diagnostic-evidence.md]
key-decisions:
  - "D-141 closes the prior scope checkpoint while leaving real admission evidence unresolved."
  - "DIAG-01, DIAG-02, and RIGHTS-01 remain Pending; owner scope approval is not admission evidence."
patterns-established:
  - "Keep synthetic tracer results, source metadata, and real hardware evidence as separate claims."
requirements-completed: []
coverage:
  - id: D1
    description: "The source-bound assessment and exact 513-case inventory remain blocked, with real-byte approval refused at the seven unresolved gates."
    verification:
      - kind: integration
        ref: "ctest --preset phase1 --output-on-failure --no-tests=error -R '^phase22_(admission_assessment|fixture_admission_(contract|controls))$'"
        status: pass
      - kind: other
        ref: "python3 -I tests/scripts/verify-diagnostic-admission.py --check-assessment --repo-root . --source-revision HEAD"
        status: pass
      - kind: other
        ref: "python3 -I tests/scripts/verify-diagnostic-admission.py --require-approved --repo-root . --source-revision HEAD (assert exit 2 and scope-resolution-required)"
        status: pass
    human_judgment: false
  - id: D2
    description: "The public evidence document states the approved synthetic-plus-metadata scope and accurately describes the no-go boundary."
    verification:
      - kind: integration
        ref: "phase22_evidence_controls CTest: public documentation and claim mutations are rejected"
        status: pass
      - kind: other
        ref: "python3 -I tests/scripts/verify-diagnostic-evidence.py --check --repo-root . --source-revision HEAD --write-evidence build/phase22/evidence.json"
        status: pass
    human_judgment: false
duration: 15min
completed: 2026-11-03
status: complete
---

# Phase 22 Plan 02 Summary

**Pinned diagnostic source metadata is preserved, while seven unresolved evidence gates keep every real fixture out of Phase 22.**

## Accomplishments

- Preserved the existing assessment and inventory commits. The assessment remains `blocked`, records all 513 source/ROM pairs by tree metadata, and does not fetch real ROM or reference-image payloads or run upstream tools.
- Kept the inventory split at 480 shared-macro verdict cases, two inline verdict cases, and 31 initial no-protocol exclusions. The 482 protocol candidates remain blocked and not observed; zero are admitted, eligible, or executed. Final suite accounting is incomplete.
- Updated the public evidence document to record D-141's approved no-go, enumerate the seven unresolved build, rights, model, digest, case-applicability, and independent-oracle gates, and state that missing evidence is not a finding that an upstream license prohibits use.
- Kept DIAG-01, DIAG-02, and RIGHTS-01 Pending. Scope approval does not establish build reproducibility, rights, reference applicability, or diagnostic results.

## Historical Assessment Commits

The assessment work was already committed before this closeout; it was inspected and reverified without being repeated:

1. `559b5f72` — refuse unresolved diagnostic admission.
2. `8b036779` — add the source-bound diagnostic assessment and metadata inventory.
3. `f2542c80` — require acid2 build evidence.
4. `5a8575f9` — record the prior owner evidence checkpoint, later resolved as a scope checkpoint by D-141.

This plan's closeout commit contains the public no-go update and this summary. The historical assessment keeps its original `source_revision`; verification in this continuation ran against the current source revision.

## Verification

- `cmake --preset phase1` and `cmake --build --preset phase1` — passed.
- Focused CTest selection for `phase22_admission_assessment` and `phase22_fixture_admission_{contract,controls}` — passed all three checks; the admission contract and controls were rerun and passed.
- `verify-diagnostic-admission.py --check-assessment --repo-root . --source-revision HEAD` — passed and reported a blocked assessment with seven unresolved gates and 513 cases.
- `verify-diagnostic-admission.py --require-approved --repo-root . --source-revision HEAD` — correctly returned exit 2 with `scope-resolution-required` and all seven unresolved gate identifiers.
- The public-document claim contract is added in dependent Plan 22-10; its automated coverage must be recorded before the Phase 22 closure.

## Decisions and Limits

- D-141 approves synthetic composition and metadata-only evidence for Phase 22. It does not supply any real-fixture admission evidence.
- The pinned DMG/CGB source identities and complete gbmicrotest roster identity are supported, but do not establish output rights, model applicability, independent expected results, or successful execution.
- No real fixture was admitted or executed. No real glyph accuracy, mode-3 timing, hardware behavior, game progress, or broad compatibility is claimed.

## Next Plan

Continue with Plan 22-10's immutable metadata/no-go contract, then Plan 22-11's final qualification and phase boundary. Stop at Phase 22; Phase 23 remains owner-controlled.

---
*Phase: GB-22-composition-and-microtest-evidence*
*Plan: 02*
*Completed: 2026-11-03*
